Transplant Post-Discharge Lodging for NCI Research Participants

Amendment 2 - Revised SOW - Refer to 3.0 Scope for added requirement (Highlighted) and responses to

questions received Amendment: Extend to 3/24/26 - 4PM COMBINED SYNOPSIS / SOLICITATION (NON-COMPETITIVE) Title: Transplant Post-Discharge Lodging for NCI Research Participants

• (i) This is a combined for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The solicitation number is 75N98026Q00097 is issued as a insert request for quotation (RFQ). This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING BRAND-NAME). The (OMAS), (OA), on behalf of the National Cancer Institute (NCI), intends to negotiate and award a contract without providing for full and open competition (including brand-name) to Friends of Patients at the NIH – 9000 Rockville Pike. Bldg. 10 # 7-5521. Bethesda, MD 20892 for Transplant Post-Discharge Lodging for NCI Research Participants. This acquisition is conducted as non-competitive for a commercial product or commercial service and is conducted pursuant to FAR 12.201-1, Simplified Procedures in accordance with 41 U.S.C. 1901.
• (ii) This requirement is for the following services: Patients in clinical trials that require a bone marrow transplant, who travel from around the nation and the world-at-large to receive treatment, remaining in the Bethesda, Maryland, area is best-advised for their safety during this time. In the case of bone marrow transplantation, the participant’s condition due to their clinical response to required immune system conditioning can mean the timing for their transplantation is incredibly delicate and may need to be delayed for weeks or months at a time requiring their condition be managed closely. See attachment 1. Statement of Work (SOW)
• (iii) Description of requirement: The mission of The NCI Center for Cancer Research is to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. The CCR is home to an extraordinary group of scientists and clinicians exploring the cutting-edge of cancer and HIV/AIDS research. The unique clinical care needs presented by NCI transplant patients and the protocol requirement to stay locally to NIH during the 100-day post-transplant evaluation period, only one source will be solicited. The unique relationship between the Friends of Patients at the NIH, aligned with the availability of the lodging, close proximity to the NIH Clinical Center. See attachment 1. Statement of Work for reporting

requirements. (iii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated

period of performance is from 04/01/2026 through 03/31/2027. (v) The provisions at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the

Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this address: https://www.acquisition.gov/far-overhaul https://www.hhs.gov/contract-policies-regulations/hhsar-overhaul (End of provision) a) The following FAR provisions are required by FAR 12.2025(a), and incorporated by reference: • FAR 52.212-1,